Leaders of the D.S.M., the world’s most influential psychiatric manual, have been split for more than five years over whether ...

In a breakthrough study, scientists have discovered that a variant in one gene, GRIN2A, can directly cause mental illness – something previously believed to be the result of several mutations working ...

Patients with childhood-onset Sjögren disease exhibited distinct disease patterns characterized by high or low disease activity and high or low symptom burden during adolescence and young adulthood. A ...

Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

Panelists discuss how understanding and managing the full range of schizophrenia symptoms is key to improving long-term patient outcomes. Panelists discuss how schizophrenia presents a wide spectrum ...

Tourette syndrome often begins in childhood. But for many patients, its challenges and care needs continue into adulthood. From early recognition and behavioral interventions to managing transitions ...

German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...

Globally, sepsis infection is the leading cause of death in children, taking more than 3.4 million lives per year, according to the Sepsis Alliance — and 85% of these deaths occur before age 5. Sepsis ...

Panelists discuss how negative symptoms of schizophrenia differ from positive and cognitive symptoms, explaining that negative symptoms involve withdrawal, flat affect, and poverty of thought rather ...

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that ...